Liver Tumor Promoting Effects of Fenbendazole in Rats

Toxicologic Pathology

Volumn 27, Issue 5, 1999, Pages 553-562

  Shoda, Toshiyuki ^a   Onodera, Hiroshi ^a   Takeda, Makio ^a   Uneyama, Chikako ^b   Imazawa, Takayoshi ^b   Takegawa, Kiyoshi ^b   Yasuhara, Kazuo ^b   Watanabe, Tomoyuki ^b   Hirose, Masao ^c   Mitsumori, Kunitoshi ^c  

^a INSTITUTE OF ENVIRONMENTAL TOXICOLOGY   (Japan)

^b Hamamatsu University School of Medicine   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

Author keywords

benzimidazole; carcinogenesis; Connexin; cytochrome P 450; promotion

Indexed keywords

CYTOCHROME P450; DIETHYLNITROSAMINE; FENBENDAZOLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; IN SITU HYBRIDIZATION; LIVER HYPERTROPHY; LIVER TUMOR; LIVER WEIGHT; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH ENDOPLASMIC RETICULUM;

ALKYLATING AGENTS; ANIMALS; ANTINEMATODAL AGENTS; BLOTTING, WESTERN; BODY WEIGHT; CARCINOGENICITY TESTS; COCARCINOGENESIS; CONNEXINS; CYTOCHROME P-450 ENZYME SYSTEM; DIETHYLNITROSAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FENBENDAZOLE; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INJECTIONS, INTRAPERITONEAL; ISOENZYMES; LIVER; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICROSCOPY, ELECTRON; ORGAN SIZE; RATS; RATS, INBRED F344; RNA, MESSENGER;

ANIMALIA;

EID: 0032832828     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262339902700509     Document Type: Article

References (24)

1. Dalvi RR (1989). Comparative studies on the effect of fenbendazole on the liver and liver microsomal enzymes in goats, quail and rats. Vet. Res. Commun. 13: 135-139.
2. Dalvi RR, Gawai KR, and Dalvi PS (1991). Lack of in vivo and in vitro effects of fenbendazole on phase I and phase II biotransformation enzymes in rats, mice and chickens. Vet. Hum. Toxicol. 33: 548-551.
3. Diwan BA, Rice JM, Nims RW, Lubet RA, Hu H., and Ward JM (1988). P450 enzyme induction by 5-ethyl-5-phenylhydantoin and 5,5-diethylhydantoin, analogues of barbiturate tumor promoters phenobarbital and barbital, and promotion of liver and thyroid carcinogenesis initiated by N-nitrosodiethylamine in rats. Cancer Res. 48: 2492-2497.
4. Diwan BA, Rice JM, Ohshima M., Ward JR, and Dove LF (1985). Comparative tumor-promoting activities of phenobarbital, amobarbital, barbital sodium and barbituric acid on livers and other organs of male F344/NCr rats following initiation with N-nitrosodiethylamine. J. Natl. Cancer Inst. 74: 509-515.
5. Fujisawa H., Takeda M., Yoshida T., and Chiba Y. (1996). In situ hybridization technique using digoxygenin-labeled cRNA probe for rat Cx32 mRNA. Jpn. J. Histotechnol. 5: 13-18.
6. Gleizes C., Eeckhoutte C., Pineau T., Alvinerie M. and Galtier P. (1991). Inducing effect of oxfendazole on cytochrome P4501A2 in rabbit liver. Biochem. Phannacol. 41: 1813-1820.
7. Hertzberg EL (1984). A detergent-independent procedure for the isolation of gap junctions from rat liver. J. Biol. Chem. 259: 9936-9943.
8. Isogai M., Shimada N., Kamataki T., Imaoka S., and Funae Y. (1993). Changes in the amount of cytochrome P450 in rat hepatic microsomes produced by cyclosporin A. Xenobiotica 23: 799-807.
9. Ito N., Hasegawa R., Imaida K., Hirose M., and Shirai T. (1996). Medium-term liver and multi-organ carcinogenesis bioassays for carcinogens and chemopreventive agents. Exp. Toxicol. Pathol. 48: 113-119.
10. Klaunig JE and Ruch RJ (1990). Role of inhibition of intercellular communication in carcinogenesis. Lab. Invest. 62: 135-146.
11. Krutovskikh VA, Mesnil M., Mazzoleni G., and Yamasaki H. (1995). Inhibition of rat liver gap junction intercellular communication by tumor-promoting agents in vivo. Lab. Invest. 72: 571-577.
12. Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.
13. Lubet RA, Nims RW, Ward JM, Rice JM, and Diwan BA (1989). Induction of cytochrome P450b and its relationship to liver tumor promotion. J. Am. Coll. Toxicol. 8: 259-268.
14. Mesnil M., Piccoli C., and Yamasaki H. (1993). An improved long-term culture of rat hepatocytes to detect liver tumor-promoting agents: Results with phenobarbital. Eur. J. Pharmacol. Environ. Toxicol. Pharmacol. Sect. 248: 59-66.
15. Mitsumori K., Onodera H., Shoda T., Uneyama C., Imazawa T., Takegawa K., Yasuhara K., Watanabe T., and Takahashi M. (1997). Liver tumor-promoting effects of oxfendazole in rats. Food Chem. Toxicol. 35: 799-806.
16. Neveu MJ, Babcock KL, Hertzberg EL, Paul DL, Nicholson BJ, and Pitot HC (1994). Colocalized alterations in connexin 32 and cytochrome P450IIB1/2 by phenobarbital and related liver tumor promoters. Cancer Res. 54: 3145-3152.
17. Neveu MJ, Hully JR, Babcock KL, Hertzberg EL, Nicholson BJ, Paul DL, and Pitot HC (1994). Multiple mechanisms are responsible for altered expression of gap junction genes during oncogenesis in rat liver. J. Cell Sci. 107: 83-95.
18. Neveu MJ, Hully JR, Paul DL, and Pitot HC (1990). Reversible alteration in the expression of the gap junctional protein connexin 32 during tumor promotion in rat liver and its role during cell proliferation. Cancer Commun. 2: 21-31.
19. Peraino C., Fry Rjm, Staffeldt E., and Christopher JP (1975). Comparative enhancing effects of phenobarbital, amobarbital, diphenylhydantoin and dichlorodiphenyltrichloroethane on 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. Cancer Res. 35: 2884-2890.
20. Sato K. (1988). Glutathione S-transferase and hepatocarcinogenesis. Jpn. J. Cancer Res. (Gann) 79: 556-572.
21. Shinozuka H., Lombardi B., and Abanobi SE (1982). A comparative study of the efficacy of four barbiturates as promoters of the development of γ-glutamyltranspeptidase-positive foci in the liver of carcinogen treated rats. Carcinogenesis 3: 1017-1020.
22. Takeda A., Kanoh M., Shimazu T., and Takeuchi N. (1988). Monoclonal antibodies recognizing different epitopes of the 27-kDa gap junction protein in rat liver. J. Biochem. 104: 901-907.
23. World Health Organization (1991). WHO Food Additive Series, No. 29. Toxicological Evaluation of Certain Veterinary Drug Residues in Food: Thirty-Eighth Meeting of the Joint FAO/WHO Expert Committee on Food Additives. World Health Organization, Geneva, pp. 45-77.
24. World Health Organization (1996). WHO Technical Report Series, No. 864. Evaluation of Certain Veterinary Drug Residues in Food: Forty-Fifth Report of the Joint FAO/WHO Expert Committee on Food Additives. World Health Organization, Geneva, pp. 21-26.